{"id":"W2776524664","doi":"10.14740/jocmr3168w","title":"A Multiple Treatment Comparison of Eleven Disease-Modifying Drugs Used for Multiple Sclerosis","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fingolimod; Alemtuzumab; Adverse effect; Multiple sclerosis; Natalizumab; Placebo; Internal medicine; Quality of life (healthcare); Disease; Intensive care medicine; Alternative medicine; Immunology; Transplantation; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01339632,0.0003079649,0.00276871,0.0006121912,0.000772004,0.00005710706,0.0009195031,0.0002108246,0.00008192079],"category_scores_gemma":[0.1343176,0.0001911803,0.0009578231,0.0002380671,0.002262765,0.0002327671,0.0003363841,0.00132088,0.00001098451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002919425,"about_ca_system_score_gemma":0.001048764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003717051,"about_ca_topic_score_gemma":0.0001239705,"domain_scores_codex":[0.9912884,0.0008047362,0.003201057,0.0004971597,0.00329317,0.0009154346],"domain_scores_gemma":[0.9692469,0.02232687,0.001834216,0.001322986,0.003706204,0.001562872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01024876,0.002646209,0.8304895,0.0005865804,0.0008920306,0.00004038952,0.001230821,0.00001222812,0.00888723,0.00001986974,0.008064134,0.1368823],"study_design_scores_gemma":[0.04260651,0.01302177,0.9070321,0.004141838,0.000393156,0.000005843763,0.002355149,0.01103542,0.005442354,0.00015194,0.01363149,0.0001824584],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9718829,0.002280194,0.0004337216,0.02229576,0.0005872472,0.002061148,0.00005406182,0.00001576407,0.0003891529],"genre_scores_gemma":[0.9892491,0.00457075,0.002684716,0.00004869608,0.002907541,0.00009589908,0.00001007405,0.00005361647,0.0003796452],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1366998,"threshold_uncertainty_score":0.8729744,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.7017773381801795,"score_gpt":0.615871764405365,"score_spread":0.08590557377481456,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}